NEW YORK (Reuters Health) – Toremifene significantly decreases new vertebral fractures in younger men receiving androgen deprivation therapy (ADT) for prostate cancer, researchers report in an October 19th…
NEW YORK (Reuters Health) – In patients with chronic coronary artery disease, prasugrel overcomes high on-clopidogrel platelet reactivity more effectively than doubling the dose of clopidogrel, results of…
NEW YORK (Reuters Health) – Hospitalized nonsurgical patients (medical patients and those with acute stroke) should receive pharmacologic venous thromboembolism (VTE) prophylaxis, unless the risk for bleeding outweighs…
NEW YORK (Reuters Health) – All women found to have vulvar intraepithelial neoplasia (VIN) require some form of treatment and follow-up surveillance, according to recommendations from The American…
NEW YORK (Reuters Health) – The institution of lipid-lowering therapy has significantly reduced mortality in patients with homozygous familial hypercholesterolemia (FH), researchers from South Africa report in the…
NEW YORK (Reuters Health) – Prasugrel helps stop thrombotic events in patients who undergo percutaneous coronary intervention (PCI), but associated “nuisance” bleeding may prompt discontinuation of such therapy,…
NEW YORK (Reuters Health) – Polycystic ovary syndrome (PCOS) does not appear to increase the risk of cardiovascular events among postmenopausal women, researchers from Sweden report in the…
NEW YORK (Reuters Health) – One in five of patients with congenital heart disease need surgery in adulthood, and reoperations make up about 40% of these surgeries, according…
NEW YORK (Reuters Health) – The rate of deep vein thrombosis or pulmonary embolism is twice as high among surgical patients in the US with inflammatory bowel disease…
